- This event has passed.
APhA’s Pharmacy-Based Cardiovascular Disease Risk Management Certificate Program
April 4, 2020 @ 8:00 am - 5:00 pm
Update: In light of the COVID-19 Pandemic and the closing and cancellations surrounding it, OSPA is putting this event on hold until further notice. We will update with more information as soon as it is available.
Hosted by: Oregon State Pharmacy Association
Lancaster Family Health Center
255 Lancaster Drive NE
Salem, Oregon 97301
For questions about this program, please contact OSPA at firstname.lastname@example.org
APhA’s Pharmacy-Based Cardiovascular Disease Risk Management is an interactive certificate training program that explores the pharmacist’s role in cardiovascular disease risk management. This practice-based activity is the first step for pharmacists interested in learning the essential skills to successfully assess risk, promote cardiovascular disease prevention, and encourage patient adherence to therapy.
The goals of this program are to:
- Educate pharmacists on current evidence-based treatment goals and clinical management recommendations for dyslipidemia and hypertension.
- Familiarize pharmacists with important concepts related to healthful lifestyle changes that focus on cardiovascular disease prevention.
- Introduce techniques and skills for encouraging patient adherence to prescribed therapies.
- Ensure pharmacist proficiency in blood pressure measurement technique and point-of-care lipid testing.
- Enhance pharmacist experience in applying elements of motivational interviewing with respect to medication adherence and lifestyle modifications.
APhA’s Pharmacy-Based Cardiovascular Disease Risk Management certificate training program has two components: web-based interactive self-study with assessment and the live seminar with online final assessment. A Certificate of Achievement will be awarded to participants who successfully complete all program components, including an evaluation.
Key Learning Objectives of the Live Training Seminar
- Assess a patient’s risk for atherosclerotic cardiovascular disease.
- Describe how to use patient factors that are not included in risk calculators to guide treatment selections.
- Explain how to apply national treatment guidelines for hypertension and dyslipidemia to individual patients.
- Discuss how to identify patients who are appropriate for the use of aspirin for primary prevention.
- Describe how treatment approaches for dyslipidemia and hypertension should be modified for special populations, including those with diabetes, renal insufficiency, and elevated hepatic transaminase levels.
- Recommend appropriate lifestyle interventions that reduce cardiovascular risk.
- Apply patient education and counseling strategies, including motivational interviewing, to support lifestyle modifications.
- Demonstrate how to measure blood pressure.
- Discuss the use of point-of-care lipid testing in cardiovascular risk management.
- Discuss how to implement cardiovascular risk management services in various practice settings, including potential billing options and quality measures.
For a complete list of learning objectives and for all APhA accreditation information and policies, please visit the APhA website here.
- Check-in and Continental Breakfast
- Welcome, Introductions and Acknowledgements
- Cardiovascular Disease Risk Assessment and Treatment Decisions
- Morning Break
- Special Situations and Clinical Updates
- Lifestyle Modifications and Motivational Interviewing
- Motivational Interviewing Activity
- Patient Assessment Skills
- Blood Pressure Measurement Practice
- Afternoon Break
- Business and Practice Models
- Transitions of Care Patient Case
- Take Home Points and Final Instructions
The Oregon State Pharmacy Association is offering attendees the member price of $375.
Adriane N Irwin, MS, PharmD, BCACP, CDE
Clinical Associate Professor – Ambulatory Care
OSU/OHSU College of Pharmacy
Natalea Braden-Suchy, PharmD, BCACP
Clinical Assistant Professor
OSU/OHSU College of Pharmacy
Continuing Pharmacy Education (CPE) Information and Activity Completion Requirements
Release Date: 09/01/2018;
Expiration Date: 09/01/2021 PLEASE NOTE: NO Home Study credit granted after this date; Live Credit can only be granted within 60 days from the day of the seminar attended or by the expiration date, whichever is sooner.
Activity Type: Practice-based
Learning Level: 2 — Experience with the topic is recommended, but advanced expertise or specialty practice in the subject area is not necessary. This activity will focus on expanding the learner’s knowledge and application of new and/or more complex information.
Target Audience: Pharmacists in all practice settings
- Successful completion of the self-study component involves passing the self-study assessment with a grade of 70% or higher and will result in 12 contact hours of CPE credits (1.2 CEUs). ACPE Universal Activity Number: 0202-9999-18-247-H01-P
- Successful completion of the live seminar component involves attending the full live seminar, passing the final assessment with a grade of 70% or higher and completing a skills assessment. Successful completion of this component will result in 8 contact hours of CPE credit (0.80 CEU). ACPE Universal Activity Number: 0202-9999-18-248-L01-P
Once credit is claimed, Statements of Credit will be available online within 24 hours on participant’s CPE Monitor profile at https://nabp.pharmacy/cpe-monitor-service/. The Certificate of Achievement will be available online upon successful completion of the necessary activity requirements on the participant’s “My Training” page on www.pharmacist.com.
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Activity Requirements – Course material and exams will be accessed online – In order to participate in this activity, registrants must have access to a computer with minimum system requirements: Internet connectivity with current version of internet browsers, such as Chrome, Microsoft Edge, Firefox, Safari, or Internet Explorer; Adobe Acrobat Reader, Flash Player 8 or higher, Operating Systems: Windows 10, XP, 7 0r 8, Vista; Mac OSX, Android & iOS devices; Hardware: 128MB MB of free memory (not 128 MB total), and Audio: Sound card and speakers or earphones. Please note iPads do not currently allow Adobe Support to be downloaded onto the device .For full technology requirements, please visit http://elearning.pharmacist.com/technology-troubleshooting
APhA’s Pharmacy-Based Cardiovascular Disease Risk Management was developed by the American Pharmacists Association.
Cancellation Policy and Additional Fees:
Please note: Once the online program code has been redeemed, no refund will be issued. If the participant has redeemed the online program code, but fails to complete either the self-study or the live component of the program, the participant will not receive credit for participation in the program, will not receive a certificate of completion and will be required to register for a later program, pay an additional registration fee and retake the program at a later date.
Once the participant has redeemed the online program code, the participant shall be responsible for all activity thereafter. If a participant redeems a code more than once, the participant will be charged a fee for each additional code redeemed ($125).
On the day of the seminar, participants who have successfully completed the live seminar will receive directions to complete their final exam outside of class. Please note: the test will need to be completed within a few days of the program.
Refunds, less a $75 handling charge, will be issued for written cancellation requests received by OSPA no later than two weeks before the program date. If a cancellation is received within two weeks of the program date, or if online code has already been redeemed, no refund will be issued.
If the required minimum number of registrants is not met (ten), OSPA reserves the right to cancel the program, in which case, full refunds will be made to all registrants. Access codes to course materials will not be distributed prior to reaching the minimum registrations.